Coronavirus

News

Digital health predicted as the new normal in COVID aftermath

US Congress faces pressure to maintain telehealth after COVI...

The coronavirus pandemic has forced healthcare systems around the world to make greater use of telehealth services during lockdown, and lawmakers in the US want to see if those

News

Gilead finally breaks its silence on remdesivir’s price

After weeks of speculation, Gilead Sciences has revealed its pricing plans for coronavirus drug remdesivir – and the rationale behind its decision.

News

US advisors add steroids to COVID-19 drug recommendations

The Infectious Diseases Society of America (IDSA) says generic steroids should be used to treat patients hospitalised with COVID-19.

Views & Analysis

The real impact of COVID-19 on emerging markets

When COVID-19 began to spread uncontrollably, numbers of confirmed cases initially grew most quickly in developed economies across China, Europe and then the US.

News

COVID-19 drug remdesivir recommended for EU approval

The EMA’s human medicines committee (CHMP) has recommended granting a conditional marketing authorisation to Gilead’s COVID-19 treatment remdesivir – making it the first drug of its kind to be g

Views & Analysis